US pharma giants Pfizer and Moderna have released the results of clinical trials of their respective experimental coronavirus vaccines. Both vaccine candidates have reportedly shown an efficacy rate of over 90 per cent.
At the same time, the first batch of the Russian Sputnik-V coronavirus vaccine is set to arrive at the Ganesh Shankar Vidyarthi Medical College in Kanpur, Uttar Pradesh. Clinical trials for this Covid-19 vaccine candidate will be held as per the agreement between Dr Reddy’s and the Russian Direct Investment Fund (RDIF).
As per the Ministry of Health and Family Welfare’s coronavirus dashboard, last updated at 8 am Tuesday, India has 4,53,401 active cases of coronavirus. As many as 82,90,370 patients have been discharged after recovering from the infection while Covid-19 has claimed 1,30,519 lives across the country to date.
发表回复